Blog

The ‘ballroom’ concept is the much trumpeted vision of the pharmaceutical ‘factory of the future’ but does this development create new safety risks for employees?

As the advantages of single-use systems become more widely recognised across the biopharmaceutical industry, there is a move from facilities with fixed equipment to laboratories that are agile, modular and able to react quickly to changing demands.

Alongside single-use systems, the ballroom concept continues to transform biopharmaceutical manufacturing operations. The core idea behind the ballroom concept is the need for process equipment to be mobile, achieved through mounting equipment on ...

The manufacture of biopharmaceutical products is a complex process. In addition to the challenges facing most manufacturers, biopharmaceutical companies also have to work within highly controlled cleanroom environments, which are enclosed areas ...

The pharmaceutical industry places a high importance on safety, and this includes the handling of materials. Within pharmaceutical manufacturing, it is crucial to have systems and procedures in place to ensure that materials and equipment are ...

As single-use systems become adopted across the pharmaceutical industry, there is a shift from fixed equipment facilities to modern, agile, and modular-based processes that enable fast changeovers and improved responsiveness to changing needs and ...

As the biopharma industry continues shifting towards a more mobile and modular facility design, the benefits of increased flexibility, agility, and decreased capital costs are quickly being realised by manufacturers of all shapes and sizes.